BXM Wealth’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

BXM Wealth’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,690	Closed	-$213K	–	167
2026 Q1	$213K	Sell	8,690 -300	-3%	-$7.8K	0.16%	124
2025 Q4	$243K	Buy	+8,990	New	+$242K	0.19%	111

Other funds holding FMED

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

BXM Wealth's FMED Position: Q2 2026 in Review

BXM Wealth sold out of Fidelity Disruptive Medicine ETF (FMED) in Q2 2026, closing a stake of 8,690 shares — an estimated $213K sold.

BXM Wealth first reported a position in FMED in Q4 2025 and held it in 2 quarters. The position peaked at $243K in Q4 2025. 3 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

BXM Wealth reported no remaining Fidelity Disruptive Medicine ETF position as of Q2 2026 after selling out during the quarter.
BXM Wealth sold 8,690 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $213K.
BXM Wealth first reported a position in Fidelity Disruptive Medicine ETF in Q4 2025 and held it in 2 quarters.
BXM Wealth's Fidelity Disruptive Medicine ETF position peaked at $243K in Q4 2025.
3 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.